Allist Medicine raised 1.18 billion yuan in its first round of financing, led by Shiyu Capital.
The company was formed in 2004, focusing on the development of innovative medicines that has both medical and marketing strengths. By now, Allist Medicine has deployed respective research lines in fields of major diseases such as diabetes and cancer. It has completed the applications of more than 50 domestic and oversea patents, as well as reports of numerous new medicines.
(picture source: www.allist.com.cn）